Could novel biosensors facilitate SARS-CoV-2 antiviral drug research?

By | August 2, 2021
An intriguing new study presents a novel approach to biosensor-based evaluation of promising drugs that could inhibit the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via its 3C-like protease (3CLpro), a viral protease.